Notes - Segment Information

Astellas Pharma Inc. - Filing #7577637

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
As at
2022-03-31
2021-04-01 to
2021-12-31
2021-10-01 to
2021-12-31
Notes - Segment information
Segment information
Revenue
Revenue
1,164,365,000,000 JPY
402,180,000,000 JPY
992,293,000,000 JPY
340,627,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
1,371,000,000 JPY
-407,000,000 JPY
2,032,000,000 JPY
1,724,000,000 JPY
Profit (loss) before tax
180,238,000,000 JPY
59,758,000,000 JPY
167,402,000,000 JPY
78,317,000,000 JPY
Assets
2,513,948,000,000 JPY
2,332,395,000,000 JPY
Investments accounted for using equity method
12,601,000,000 JPY
10,035,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.